Delivery Order SPE2DB22D2005-SPE2DB25FJKF3

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.98 firm fixed-price delivery order is for 4,566,064,257 units of Citalopram HBR 40 mg tablets, with an ultimate completion date of October 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA), a defense agency, for the delivery of Citalopram HBR 40 mg tablets. The $5,663.20 firm-fixed-price delivery order has a performance period ending on May 7, 2025. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,978.05 firm fixed-price delivery order is for the supply of 4565098256 - CITALOPRAM HBR 40 MG TABLET 500S, a medication used to treat mental health conditions. The contract has a completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,701.15, is for the delivery of 4563063713 CITALOPRAM HBR 40 MG TABLET 100S. The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,010.81 firm fixed price delivery order is for the provision of 4567314544 - CITALOPRAM HBR 40 MG TABLET 500S, a generic pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,869.83 firm fixed-price delivery order is for the supply of Citalopram HBR 40 mg tablets, with a performance period ending on September 25, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D2014|SPE2DB24FC17J, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,239.42 firm fixed-price delivery order is for the supply of 4564847088 - CITALOPRAM HBR 40 MG TABLET 500S, with a performance period through June 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,181.32 firm fixed-price delivery order is for the supply of 4560628942 CITALOPRAM HBR 40 MG TABLETS in quantities of 500. The contract has an ultimate completion date of April 19, 2023 and is not set-aside for any specific business category. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJKF3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,201.19 firm-fixed-price delivery order contract is for the supply of 4567692604 CITALOPRAM HBR 40 MG TABLET 500S, with a period of performance through March 26, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is part of that larger IDC, enabling efficient government procurement of essential pharmaceutical and medical commodities to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract did not have any set-aside designation, indicating open competition.

Generated 6/24/25, 10:04 AM